The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
Published
The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter.…
#humana #club #refinitiv #eps #humanaytdhumana #jimcramer #morningmeeting #sp500 #unitedhealthgroup #unh